CKAP2 (cytoskeleton associated protein 2) is a new prognostic marker in HER2-negative luminal breast cancer

被引：0
|
作者：
Sim, S. H.
Bae, C-D
Kwon, Y.
Park, I. H.
Lee, K. S.
Jung, S-Y
Lee, S.
Kang, H-S
Lee, E. S.
Kim, H-S
Hong, K-M
Ro, J.
机构：
[1] Natl Canc Ctr, Ctr Breast Canc, Goyang, South Korea
[2] Natl Canc Ctr, Res Inst, Goyang, South Korea
[3] Sungkyunkwan Univ, Sch Med, Suwon, South Korea
[4] Inje Univ, Ilsan Paik Hosp, Goyang, South Korea
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-08-25
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-08-25
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Bevacizumab in the treatment of HER2-negative breast cancer
    Lorusso, Vito
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 813 - 821
  • [22] Luminal (Her2 negative) prognostic index and survival of breast cancer patients
    Chen, Xuesong
    Cong, Yingying
    Pan, Lihua
    Jiang, Ying
    Meng, Qingwei
    Sun, Lichun
    Pang, Hui
    Zhao, Yanbin
    Dong, Xiaoqun
    Cai, Li
    CANCER EPIDEMIOLOGY, 2014, 38 (03) : 286 - 290
  • [23] Salivary Tryptophan as a Metabolic Marker of HER2-Negative Molecular Subtypes of Breast Cancer
    Sarf, Elena A.
    Dyachenko, Elena I.
    Bel'skaya, Lyudmila V.
    METABOLITES, 2024, 14 (05)
  • [24] Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer
    Yue, Meng
    Wu, Si
    Liu, Chang
    Cai, Lijing
    Wang, Xinran
    Jia, Ying
    Han, Dandan
    Liu, Yueping
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 373 - 381
  • [25] Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer
    Meng Yue
    Si Wu
    Chang Liu
    Lijing Cai
    Xinran Wang
    Ying Jia
    Dandan Han
    Yueping Liu
    Breast Cancer Research and Treatment, 2024, 203 : 373 - 381
  • [26] The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study
    Coriano, Matilde
    Tommasi, Chiara
    Dinh, Anh Thi Lan
    Needham, Jazmine
    Aziz, Hala
    Joharatnam-Hogan, Nalinie
    Cunningham, Niamh
    Waterhouse, Jasmin
    Sun, Mingze
    Turkes, Fiona
    Pellegrino, Benedetta
    Mcgrath, Sophie
    Okines, Alicia
    Parton, Marina
    Turner, Nicholas
    Johnston, Stephen
    Musolino, Antonino
    Ring, Alistair
    Battisti, Nicolo Matteo Luca
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (03) : 603 - 614
  • [27] Heterogeneity and prognostic characteristics of HER2-low breast cancer: A retrospective analysis of patients with HER2-negative metastatic breast cancer
    Lv, Huimin
    Yan, Min
    Zhang, Mengwei
    Niu, Limin
    Zeng, Huiai
    Sun, Huihui
    Zhao, Shengnan
    Wang, Jing
    CANCER RESEARCH, 2024, 84 (09)
  • [28] HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells
    Duru, Nadire
    Fan, Ming
    Candas, Demet
    Menaa, Cheikh
    Liu, Hsin-Chen
    Nantajit, Danupon
    Wen, Yunfei
    Xiao, Kai
    Eldridge, Angela
    Chromy, Brett A.
    Li, Shiyong
    Spitz, Douglas R.
    Lam, Kit S.
    Wicha, Max S.
    Li, Jian Jian
    CLINICAL CANCER RESEARCH, 2012, 18 (24) : 6634 - 6647
  • [29] Subtype-specific prognostic impact of Bcl-2 in HER2-positive and HER2-negative breast cancer
    Taeyeong Kim
    Seung Taek Lim
    Hyang Suk Choi
    In-Jeong Cho
    Hany Noh
    Jong-In Lee
    Airi Han
    Scientific Reports, 15 (1)
  • [30] Transient phosphorylation of tumor associated microtubule associated protein (TMAP)/cytoskeleton associated protein 2 (CKAP2) at Thr-596 during early phases of mitosis
    Kyung Uk Hong
    Yong-Bock Choi
    Jung-Hwa Lee
    Hyun-Jun Kim
    Hye-Rim Kwon
    Yeon-Sun Seong
    Heung Tae Kim
    Joobae Park
    Chang-Dae Bae
    Kyeong-Man Hong
    Experimental & Molecular Medicine, 2008, 40 : 377 - 386
12345